Acta Pharmacol Sin. 2022 Nov;43(11):2946-2955.doi: 10.1038/s41401-022-00893-8. Epub 2022 Apr 6.
2022-11-05Acta Pharmacol Sin. 2022 Nov;43(11):2946-2955.doi: 10.1038/s41401-022-00893-8. Epub 2022 Apr 6. Promoter methylation-regulated miR-148a-3p inhibits lung adenocarcinoma (LUAD) progression by targeting MAP3K9 启动子甲基化调控的miR-148a-3p通过靶向MAP3K9抑制肺腺癌(LUAD)的进展